Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasper Tromp

Showing results (121-130 of 200) with videos related to

Pageof 20
Sort By:
Journal of Cardiac Failure|March 13, 2025
Activation of Neutrophil Extracellular Trap Formation in Patients with Heart Failure and a Preserved Ejection FractionBart J VAN Essen, Jasper Tromp, Andreas B Gevaert, et al.
Circulation|April 4, 2022
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE TrialMikhail N Kosiborod, Christiane E Angermann, Sean P Collins, et al.
European Journal of Heart Failure|July 9, 2024
Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSEJoão Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, et al.
Cardiovascular Research|July 15, 2021
Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHFGeorge Markousis-Mavrogenis, Jasper Tromp, Wouter Ouwerkerk, et al.
The Lancet. Global Health|February 23, 2020
Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort studyJasper Tromp, Sahiddah Bamadhaj, John G F Cleland, et al.
Journal of Cardiac Failure|January 26, 2021
The Additive Prognostic Value of Serial Plasma Interleukin-6 Levels over Changes in Brain Natriuretic Peptide in Patients with Acute Heart FailureGeorge Markousis-Mavrogenis, Jasper Tromp, Robert J Mentz, et al.
JACC. Heart Failure|April 11, 2021
Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HFJasper Tromp, Wouter Ouwerkerk, John G F Cleland, et al.
European Journal of Heart Failure|July 30, 2024
Biomarker profiles associated with reverse ventricular remodelling in patients with heart failure and a reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trialJasper Tromp, Carolyn S P Lam, Wendimagegn Alemayehu, et al.
European Journal of Heart Failure|August 4, 2023
Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: Findings from EMPULSEJoão Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, et al.
JACC. Heart Failure|September 7, 2023
Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF RegistryJasper Tromp, Justin A Ezekowitz, Wouter Ouwerkerk, et al.
Pageof 20

Showing results (121-130 of 200) with videos related to

Sort By:
Pageof 20
Journal of Cardiac Failure|March 13, 2025
Activation of Neutrophil Extracellular Trap Formation in Patients with Heart Failure and a Preserved Ejection FractionBart J VAN Essen, Jasper Tromp, Andreas B Gevaert, et al.
Circulation|April 4, 2022
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE TrialMikhail N Kosiborod, Christiane E Angermann, Sean P Collins, et al.
European Journal of Heart Failure|July 9, 2024
Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSEJoão Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, et al.
Cardiovascular Research|July 15, 2021
Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHFGeorge Markousis-Mavrogenis, Jasper Tromp, Wouter Ouwerkerk, et al.
The Lancet. Global Health|February 23, 2020
Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort studyJasper Tromp, Sahiddah Bamadhaj, John G F Cleland, et al.
Journal of Cardiac Failure|January 26, 2021
The Additive Prognostic Value of Serial Plasma Interleukin-6 Levels over Changes in Brain Natriuretic Peptide in Patients with Acute Heart FailureGeorge Markousis-Mavrogenis, Jasper Tromp, Robert J Mentz, et al.
JACC. Heart Failure|April 11, 2021
Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HFJasper Tromp, Wouter Ouwerkerk, John G F Cleland, et al.
European Journal of Heart Failure|July 30, 2024
Biomarker profiles associated with reverse ventricular remodelling in patients with heart failure and a reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trialJasper Tromp, Carolyn S P Lam, Wendimagegn Alemayehu, et al.
European Journal of Heart Failure|August 4, 2023
Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: Findings from EMPULSEJoão Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, et al.
JACC. Heart Failure|September 7, 2023
Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF RegistryJasper Tromp, Justin A Ezekowitz, Wouter Ouwerkerk, et al.
Pageof 20